ClinicalTrials.gg
CompletedNCT03960320Updated May 23, 2019

Health Related Quality of Life of Patients With Abdominal Wall Defects

An observational study in Quality of Life, Abdominal Wall Defect and Gastroschisis, sponsored by Universität des Saarlandes. Completed. Open to participants aged 1 Day to 40 Years. Per ClinicalTrials.gov, last updated 2019-05-23.

Sponsored by Universität des Saarlandes · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
65
Ages
1 Day to 40 Years
Sex
All
01

Study summary

Examination of the health-related quality of life of patients operated on due to congenital defects of the abdominal wall after birth with the questionnaires KINDL, SDQ and SF-36.

Read the detailed description

Data of all patients with a congenital abdominal wall defect (CAWD) undergoing surgical repair between 1996 and 2011 in the Department of Pediatric Surgery of the Clinic for General Surgery, Visceral, Vascular and Pediatric Surgery of the Saarland University Medical Center in Homburg were retrieved from surgical health records. Up to 2001 these records were paper based and later on electronically available (SAP enhancement package 7 for SAP ERP 6.0: 2013, Walldorf, Germany). Except epidemiological data the type of disease, data concerning birth details, pre- and postnatal course, treatment, weight and growth development have been collected electronically.

Gastroschisis or omphalocele can be simple or complex. The investigators defined complex as involvement of stenosis, atresia, ischemia, volvulus or perforation, closed or vanishing gastroschisis, and chromosomal anomalies. Giant omphalocele was considered as complex as well. The type of the primary operative procedure, primary closure of the defect or other (patch plastic etc.), was also noted. The implementation of silo technique with delayed primary closure was regarded as primary closure.

A prospective analysis was conducted by a survey with age-related questionnaires to investigate the patient´s HrQoL. The study protocol was approved by the ethical board of Aerztekammer of Saarland (Nr. 206/2013). Informed consent was given by all participating patients or their guardians.

The data collection was carried out by telephone interview, personal interview or by regular mail. The interview was always conducted by the same person, a medical student (KK). The data was collected using age related questionnaires. Together with the collection of clinical data the investigators used the validated questionnaires KINDL, SDQ and SF-36.

The KINDL questionnaire (www.KINDL.org) is a specifically developed questionnaire for children, which was developed to assess the HrQoL of life of children and adolescents. The reference values were published as part of the study "The Children and Youth Health Survey (KIGGS)" by the Robert Koch Institute, Berlin, Germany and covers the health data of 17.641 children and adolescents in Germany aged 0-17 years.

The SDQ (Strengths and Difficulties Questionnaire) is the second questionnaire that was used. The investigators used the Woerner adjustment of the SDQ as it was transferred to a German cohort.

Since there are also some adult patients in the patient collective, the investigators have also integrated the SF-36, which was developed for adolescents and adult patients.

The SF-36 is an internationally recognized and widely used questionnaire for the assessment of health-related quality of life. It records eight different dimensions (= subscales) of quality of life: physical functioning, physical role function, pain, general health perception, vitality, social functioning, emotional role function and psychological well-being. Additionally, the overall physical sum score and overall psychological sum score are listed. German reference values are available as a reference for the SF-36.

In addition, disease specific questions were asked. These included somatic and clinical data about gastrointestinal function, cosmetic aspects and scars, problems during pregnancy of the child, actual clinical health status and psycho-social development. Answers were given as precise numbers or rated according to the following LIKERT-scale with these possibilities "never-seldom-sometimes-often-always".

All data were collected and processed in an Excel spreadsheet (Microsoft® Excel®, Microsoft Corporation, Redmond, Washington, USA). The statistical analysis was carried out with SPSS (IBM® SPSS® Statistics, Version 25, International Business Machines Corporation (IBM), Armonk, New York, USA) and Excel as well.

02

Conditions studied

  • Quality of Life
  • Abdominal Wall Defect
  • Gastroschisis
  • Omphalocele

Keywords

  • KINDL
  • SDQ
  • SF-36
03

In context

Gastroschisis

42 studies on the registry are indexed under Gastroschisis; 6 are open to participants now.

This study's enrollment of 65 is above the median of 53 across 14 observational studies indexed under Gastroschisis.

Browse Gastroschisis studies →

Lead sponsor

Universität des Saarlandes is the lead sponsor of 68 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with congenital abdominal wall defect, e.g. gastroschisis or omphalocele

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Congenital abdominal wall defect
  • Surgically corrected in our department
  • Survivor

Exclusion criteria

Exclusion Criteria:

  • Not surgically corrected in our department
  • Non-Survivor
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
65 participants (actual)
Patient registry
No

Interventions

  • Otherquestionnaire

    questionnaire to assess the quality of life of children using KINDL, SDQ and SF-36

06

What researchers measure

Primary outcomes

  1. Differences of Kindl test results of participants with congenital wall defects compared to a norm sample of German healthy children

    Kindl test for measuring the quality of life of participants with congenital wall defects compared to a norm sample of German healthy children

    Time frame: Day 1. For one participant all of the questionnaires were administered in one day and for that participant the study lasted one day.

  2. Differences of SDQ test results of participants with congenital wall defects compared to a norm sample of German healthy children

    SDQ test for measuring the quality of life of participants with congenital wall defects compared to a norm sample of German healthy children

    Time frame: Day 1. For one participant all of the questionnaires were administered in one day and for that participant the study lasted one day.

  3. Differences of SF-36 results of participants with congenital wall defects compared to a norm sample of German healthy adults

    SF-36 test for measuring the quality of life of participants with congenital wall defects compared to a norm sample of German healthy adults

    Time frame: Day 1. For one participant all of the questionnaires were administered in one day and for that participant the study lasted one day.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — The publication of the data in anonymous form is planned.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03960320
Lead sponsor
Universität des Saarlandes
Responsible party
Sponsor
First posted
May 23, 2019
Start date
May 1, 2014
Primary completion
Dec 31, 2015
Completion
Dec 31, 2015
Last update
May 23, 2019

Study contacts

Clemens-Magnus Meier, MD
principal investigator · Universität des Saarlandes

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion